Substance use disorder: contraceptive options counseling

What’s New in Contraception?

Contraceptive Technology Conference!

Biologic sexism of STIs

Excess breast cancer deaths after COVID-19

Contraception for patients with medical conditions

Pelvic Floor Dysfunction

Treating vulvodynia

Puzzling Over the Hurt Down-Under

Serious Mental Illness and Contraception

New 13-Cycle Vaginal Contraceptive System

The Future of Family Planning in Post-COVID America

New ASCCP Guidelines: Implications for FP

On the alert: mood disorders during 2020 stressors

Sex in the Time of COVID-19

Challenges old and new during the pandemic

Reproductive health in the time of Covid-19

Talking about toys

Missed Pills: The Problem That Hasn’t Gone Away

Find the “yes! . . . and” rather than “no” or “but”

Digital Family Planning: the Future is Now

Irregular Bleeding Due to Contraceptives

When she’s low on libido…

Ouch! Best approaches to menstrual pain

Contraceptive efficacy: understanding how user and method characteristics play their part

Strategizing treatment for chronic heavy menstrual bleeding


Untangling the literature on obesity and contraception

High tech apps for no-tech FABM

Menstrual exacerbation of other medical conditions

From Princeton University: Thomas James Trussell (1949-2018)

The Short and Long of IUD Use Duration

Selecting a Method When Guidance Isn’t Clear-cut

Healthcare in the Time of Digital Expansion

The Scoop on Two New FDA-Approved Contraceptive Methods

Pregnancy of unknown location—meeting the challenge

Big “yes” (with caveats) to CHCs during perimenopause

The role of IUDs (LNG IUDs, too!) in emergency contraception

Combined pills’ effect on mood disorders

Abortion in the U.S.: safe, declining, and under threat

Hope for ovarian cancer screening test

Breast cancer still a small risk with some hormonal contraceptives

New treatment modality for BV

Record rate of HPV-related throat cancer

Viruses in semen potentially transmissible

Don’t Abstain from Your Role in Abstinence

Teens births declining but geographic ‘hotspots’ defy trend

Online Medical Abortion Service Effective and Safe

Do Women Really Need to Wait That Long?

Reassuring news on depression and OC use

PMDD: Genetic clues may lead to improved treatment

Breast cancer risk when there is a family history

Body weight link to breast and endometrial cancers (and 11 others)

Family Planning in 2017 and Beyond

Make Me Cry: Depression Link (Again)?

Managing implant users’ bleeding and spotting

Zika: Updated guidance for providers

Pharmacist-prescribed contraceptives

Hot off the press! 2016 MEC and SPR

Zika virus fears prompt increased request for abortion in nations outlawing abortions

Opioid use epidemic among reproductive-age women

Good news on the family planning home front!

War Against Planned Parenthood Hurts Women

Win-win for both treatment and prevention

Center of the Storm


Menopause, mood, mental acuity, and hormone therapy

Emergency contraception for teens

Postpartum Contraception: Now, Not Later

Reproductive tract infections, sexually transmitted infections, or sexually transmitted diseases: “a rose by any other name…”

Are we practicing what we preach?

Be alert to VTE in hormonal contraceptive users

LARC among teens increased 15-fold, but not enough

Brain cancer and hormonal contraception

Free tools: Easy access to the US Medical Eligibility Criteria for Contraceptive Use

Alcohol consumption when pregnancy is unwanted or unintended

Latest Data on Contraceptive Use in the United States

LateBreaker sampler from Contraceptive Technology conference

Emergency Contraceptive Pill Efficacy and BMI/Body Weight

Handout on Unintended Pregnancy and Contraceptive Choice

Ask About Withdrawal (Really!)

Rules to Practice By: Safety First and Cleanliness is Close to. . .

What’s Vanity Fair Got Against the NuvaRing?

Promising New Treatment for Hepatitis C

Numbers matter, so make them simple for patients

The Recession’s Effect on Unintended Pregnancies

Lessons Learned from the Contraceptive CHOICE Project: The Hull LARC Initiative

Applying the “New” Cervical Cytology Guidelines in Your Practice

Acute Excessive Uterine Bleeding: New Management Strategies

Medical indications for IUD use in teens

Whatever happened to PID?

Update on Emergency Contraception New and Improved

Hot off the press! 2016 MEC and SPR
August 2016


Get copies of the brand new 2016 US Medical Eligibility Criteria for Contraceptive Use (MEC) and 2016 US Selected Practice Recommendations for Contraceptive Use (SPR), along with clinical tools for using them. These updated recommendations from the Centers for Disease Control and Prevention include new recommendations and new scientific evidence on continuing recommendations. With a soon-to-appear app and currently available reference charts, PDFs, and wheels, providers can have at hand the clinical tools to provide patients with evidence-based care.

Access the recommendations and tools at CDC’s dedicated website page:

“Health care providers can use CDC’s evidence-based guidance when offering quality family planning care to their patients, including helping patients choose the most appropriate contraceptive method for individual circumstances and use that method correctly, consistently, and continuously to maximize effectiveness,” said CDC’s Kate Curtis, PhD.


What is it?

The US MEC recommends which contraceptive methods may be used safely by women who have medical conditions (such as diabetes, migraines, or depression) or who have relevant health characteristics (such as breastfeeding, recent surgery, or obesity).

Most women can use most contraceptive methods safely, including women who have a medical condition. Some medical conditions can increase the risk of some adverse effects from contraceptive. However, these women face even greater risk of adverse effects associated with pregnancy, so safe and effective contraception is important. Long-acting reversible contraceptives would be appropriate.

What’s new since the 2010 MEC?

  • New recommendations for women with the following conditions or characteristics:
    • cystic fibrosis
    • multiple sclerosis
    • using certain psychotropic drugs or St. John’s wort
  • Revised recommendations for with the following conditions:
    • postpartum;
    • breastfeeding;
    • known dyslipidemias
    • migraine headaches
    • superficial venous disease
    • gestational trophoblastic disease
    • sexually transmitted diseases
    • human immunodeficiency virus
    • women using antiretroviral therapy
  • Revised recommendations for emergency contraception, including the use of ulipristal acetate

 MEC Clinical Tools

  1. App, through iTunes
  2. PDF of CDC’s MMWR Recommendations and Reports
  3. Print document of CDC’s MMWR Recommendations and Reports
  4. Summary chart (Spanish soon)
  5. Effectiveness charts
  6. MEC Wheel


What is it?

The U.S. SPR addresses issues regarding initiation and use of specific contraceptive methods and management of certain complications. Most women can start most contraceptive methods any time, according to the CDC. Few, if any, examinations or tests are needed prior to initiation of contraception. And after initiation, routine follow-up is not a general requirement. The SPR provides recommendations for managing bleeding irregularities that can be associated with contraceptives, as well as anticipatory counseling regarding the potential for irregular bleeding.

What’s new since the 2013 SPR?

  • New recommendations for the use of medications to ease insertion of intrauterine devices and
  • Revised recommendations for starting regular contraception after the use of emergency contraceptive pills.

Clinical Tools

  1. App, through iTunes
  2. PDF of CDC’s MMWR Recommendations and Reports
  3. Print document of CDC’s MMWR Recommendations and Reports
  4. Chart on When to start a given contraceptive method
  5. Algorithms on What to do if late, missed, delayed combined hormonal contraceptive
  6. Algorithm on Management IUD in women with PID

 —Submitted by Deborah Kowal, MA, PA, President of Contraceptive Technology Communications, Inc.